INTERIM REPORT JANUARY – JUNE 2006

• Sales during the period amounted to SEK 612.7 (437.5) million, an increase of 40 percent. • Operating income amounted to SEK 212.9 (21.4) million. • Net income after tax amounted to SEK 151.4 (23.6) million. • Earnings per share for the period were SEK 1.53 (0.24). • In June Q-Med entered into a strategic partnership with Smith & Nephew concerning the treatment of osteoarthritis and received a first payment of SEK 73.5 million upon the signing of the agreement. Queries should be addressed to: Erika Kjellberg Eriksson, Vice President and CFO Tel: +46 (0)70-974 90 20. Anne Rhenman, Director Investor Relations and Corporate Communications Tel: +46 (0)70-974 90 15